Thymosin alpha 1: amino acid homology with peptide T from the human immunodeficiency virus envelope.
Nguyen. T D TD; Scheving. L A LA
Key Findings
- Thymosin‑alpha‑1 shares amino‑acid sequence similarity with HIV envelope peptide T
- This similarity could lead to cross‑reactivity between the peptide and HIV
- The cross‑reactivity might influence the development or progression of AIDS‑like symptoms
Practical Outcomes
- For most biohackers, the finding isn’t directly useful – it doesn’t change dosing or suggest new benefits. It simply suggests caution if you have HIV or are at risk, as the peptide could theoretically interact with the virus. No new protocols are recommended for general longevity or performance use.
Summary
The study found that the immune‑boosting peptide thymosin‑alpha‑1 looks a lot like a small piece of the HIV virus, which could cause the two to interact in the body and might play a role in AIDS‑like disease, but it doesn’t give any new ways to use the peptide for health or performance.
Abstract
Thymosin alpha 1 has many effects on immune function and its absence in primary immunodeficiency states produce a clinical presentation similar to the one encountered in acquired immune deficiency syndrome (AIDS). Human immunodeficiency virus (HIV), the etiologic agent of AIDS, binds to T4 helper/inducer lymphocytes through specific surface receptors which include the CD4 glycoprotein. Octapeptide T, a component of the HIV envelope, mediates the binding of HIV to its receptor. In this report, we draw attention to the similarity between the amino acid sequence of thymosin alpha 1 and peptide T and its analogues. This similarity can produce a cross-reactivity between thymosin alpha 1 and HIV and may be a factor in the pathophysiology of the acquired immuno-deficiency syndrome.
Study Information
pubmed
1987
1987-06-15T00:00:00.000Z
10.1016/0006-291x(87)91047-3